M
Massimiliano Bianchi
Researcher at Mario Negri Institute for Pharmacological Research
Publications - 9
Citations - 743
Massimiliano Bianchi is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Risk factor & Odds ratio. The author has an hindex of 7, co-authored 9 publications receiving 714 citations. Previous affiliations of Massimiliano Bianchi include Pfizer & University of Milan.
Papers
More filters
Journal ArticleDOI
Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men.
Walter Vegetti,Elvire Van Assche,Alexandra Frias,Greta Verheyen,Massimiliano Bianchi,Maryse Bonduelle,Inge Liebaers,Andre Van Steirteghem +7 more
TL;DR: The risk of a chromosomal aneuploidy in spermatozoa seems to be inversely correlated to sperm concentration and total progressive motility, which strongly suggests the presence of an interchromosomal effect of the cytogenetic rearrangement.
Journal ArticleDOI
The epidemiology of multiple births
Renata Bortolus,Fabio Parazzini,Liliane Chatenoud,Guido Benzi,Massimiliano Bianchi,Alberto Marini +5 more
TL;DR: The constant frequency of monozygotic (MZ) pregnancies over time and in different geographical areas suggests that the determination of MZ twins is largely unchanged over time, and that a genetic mechanism may have a role.
Journal ArticleDOI
Reliability of ovulation tests in infertile women
TL;DR: Urinary LH was accurate in predicting ovulation with ultrasonography as the standard for detection, but time varied widely; the nadir of BBT predicted ovulation poorly, and the BBT chart was less accurate for confirming ovulation, whereas a single serum progesterone assessment in midluteal phase seemed as effective as repeated serum progestersone measures.
Journal ArticleDOI
Risk factors for urinary incontinence in women.
Fabio Parazzini,Enrico Colli,Gianni Origgi,Matteo Surace,Massimiliano Bianchi,Guido Benzi,Walter Artibani +6 more
TL;DR: In the coming years, epidemiological research should focus particularly on the potential differences in the epidemiological characteristics of different types of UI in order to gain insight into the pathogenic mechanisms.
Journal ArticleDOI
Two-year treatment with oral contraceptives in hyperprolactinemic patients.
G. Testa,Walter Vegetti,T. Motta,F. Alagna,D. Bianchedi,Clelia Carlucci,Massimiliano Bianchi,Fabio Parazzini,Pier Giorgio Crosignani +8 more
TL;DR: The data suggest that after 2 years of follow-up, no harmful effect of OC use was observed in a group of young patients using oral contraceptives with hyperprolactinemia and no patient experienced any radiological changes during OC treatment.